IL10 and neoplasm: Finally, mice in which tumours did not develop (CANReject and CRSReject) displayed higher levels of the anti‐inflammatory cytokine, IL‐10, in the midbrain, thalamus and striatum compared to mice that developed tumours or those in which tumours regressed (Figure 5C).